MedTrace Logo

Evaluation of Respiratory Parameters in Patients With Upper Limb Lymphedema

NCT06568978 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2024-08-23

No results posted yet for this study

Summary

The aim of our study is to assess disease severity, respiratory muscle strength, respiratory functions, pectoralis minor muscle shortening, functionality, and quality of life (QoL) in patients with upper limb lymphedema (ULL), and to compare these findings with healthy controls.The disease severity was assessed using the Stillwell classification system; respiratory muscle strength was measured through maximum inspiratory and expiratory intraoral pressures (MIP, MEP, respectively); respiratory functions were evaluated with a spirometer; pectoralis minor muscle shortening was measured with a tape measure; functionality was assessed using the Disabilities of the Arm, Shoulder and Hand (DASH); and QoL was evaluated with the Lymphedema Quality of Life Questionnaire - Arm (LYMQOL-Arm).

Conditions

  • Lymphedema of Upper Limb

Interventions

OTHER

Assessments of respiratory parameters

respiratory muscle strength, respiratory function test

Sponsors & Collaborators

  • Okan University

    collaborator OTHER

  • Istanbul University - Cerrahpasa

    lead OTHER

Principal Investigators

  • Gamze Aydın, PhD · Okan University

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-20
Primary Completion
2024-06-20
Completion
2024-08-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06568978 on ClinicalTrials.gov